Enfusion Exec Sells $10K+ in Stock Amid Revenue Surge
Enfusion's CAO Valeria Gutowski sells $10,277 in company stock for tax obligations, keeping significant shares; highlights company's strong market performance.
- Latest
- Trending
Enfusion's CAO Valeria Gutowski sells $10,277 in company stock for tax obligations, keeping significant shares; highlights company's strong market performance.
ASE Technology (NYSE:ASX) hits a 12-month high at $11.78, earning a "buy" rating from StockNews.com; strong performance and investor interest ...
Discover if the iShares Select Dividend ETF is the right Large Cap Value addition to your portfolio. Analyzing performance, costs, ...
JPMorgan predicts continued outperformance of defensive sectors like Utilities, Real Estate, and Staples into Q3, favoring them over cyclical stocks.
Roche's Hemlibra braces for fierce competition from Novo Nordisk's mim8, as analysts give mixed ratings and forecasts on Roche's strategic ...
Deutsche Bank's 3% DCF growth rate signals GDP alignment; Analyst warns Oracle's rating, target price risks. AI-assisted, editor-reviewed. Learn more ...
Goldman Sachs sees S&P 500's 3.1% upside; 15x P/E on strong growth. U.S. election key risk factor, impacting 3-month to ...
Free report offers insights; earnings growth disappointing for Jinyu Bio-technology. Conditions may keep share price steady. Feedback welcomed.
This dividend stock, growing distributions at 21% p.a. since 2014, shows solid potential despite a current yield of 1.2%, below ...
ideaForge Technology saw a 28% earnings surge last year. Explore the potential and risks, plus other high-growth firms with low ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.